Cedilla
Wojciech Michowski has worked in the scientific field since 2010. Wojciech began their career as a Postdoctoral Fellow at the Dana-Farber Cancer Institute, where they also held the role of Instructor in Pathology. In 2017, they joined Harvard Medical School as an Instructor. In 2019, they joined Cedilla Therapeutics as a Scientist, and was later promoted to Senior Scientist.
Wojciech Michowski obtained their Ph.D. in Biochemistry and Molecular Biology from the International Institute of Molecular and Cell Biology in Warsaw between 2005 and 2009. Prior to that, they obtained an M.Sc. and Engineer degree in Biotechnology from Szkoła Główna Gospodarstwa Wiejskiego w Warszawie between 1999 and 2004.
This person is not in any teams
This person is not in any offices
Cedilla
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.